title: Reply: In regard to the TERISA trial.
authors: Mikhail
authors: M
authors: Kosiborod
authors: Suzanne V
authors: SV
authors: Arnold
authors: John A
authors: JA
authors: Spertus
authors: Darren K
authors: DK
authors: McGuire
authors: Patrick
authors: P
authors: Yue
authors: Ori
authors: O
authors: Ben-Yehuda
authors: Luiz
authors: L
authors: Belardinelli
authors: Bernard R
authors: BR
authors: Chaitman
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use*; D060050:Angina, Stable / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D026941:Sodium Channel Blockers / Q000627:therapeutic use*
chemical_list: D000083:Acetanilides; D004791:Enzyme Inhibitors; D010879:Piperazines; D026941:Sodium Channel Blockers